Bill Status of HB1443

  1. Home
  2. Legislation
  3. Bill Status

HB1443 - 104th General Assembly

HEALTH CARE AVAILABILITY
Last Action
03/21/2025 - House: Rule 19(a) / Re-referred to Rules Committee
Statutes Amended In Order of Appearance
New Act
30 ILCS 105/5.1030 new
Synopsis As Introduced
Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Prohibits the Board from creating an upper payment limit that is different from the Medicare Maximum Fair Price for the prescription drug product that has a Medicare Maximum Fair Price. Requires the Board to implement an upper payment limit that is the same as the Medicare Maximum Fair Price no sooner than the Medicare implementation date. Provides that Medicare Part C and D plans are not required to reimburse at the upper payment limit. Provides that the Attorney General may enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.
Actions
Date Chamber Action
01/17/2025 House Filed with the Clerk by Rep. Nabeela Syed
01/28/2025 House First Reading
01/28/2025 House Referred to Rules Committee
02/03/2025 House Added Co-Sponsor Rep. Katie Stuart
02/04/2025 House Added Co-Sponsor Rep. Diane Blair-Sherlock
02/04/2025 House Added Co-Sponsor Rep. Janet Yang Rohr
02/11/2025 House Added Co-Sponsor Rep. Theresa Mah
02/13/2025 House Added Co-Sponsor Rep. Abdelnasser Rashid
02/13/2025 House Added Co-Sponsor Rep. Mary Beth Canty
02/18/2025 House Added Co-Sponsor Rep. Kelly M. Cassidy
02/18/2025 House Assigned to Health Care Availability & Accessibility Committee
02/18/2025 House Added Co-Sponsor Rep. Will Guzzardi
02/19/2025 House Added Co-Sponsor Rep. Michelle Mussman
02/19/2025 House Added Co-Sponsor Rep. Nicolle Grasse
02/25/2025 House Added Co-Sponsor Rep. Norma Hernandez
02/25/2025 House Added Co-Sponsor Rep. Kevin John Olickal
02/25/2025 House Added Co-Sponsor Rep. Gregg Johnson
02/25/2025 House To Prescription Drug Affordability Board
02/26/2025 House Added Co-Sponsor Rep. Camille Y. Lilly
02/26/2025 House Added Co-Sponsor Rep. Suzanne M. Ness
03/04/2025 House Added Co-Sponsor Rep. Debbie Meyers-Martin
03/05/2025 House Added Co-Sponsor Rep. Anne Stava-Murray
03/07/2025 House Added Co-Sponsor Rep. Anna Moeller
03/13/2025 House Added Co-Sponsor Rep. Maura Hirschauer
03/13/2025 House Added Co-Sponsor Rep. Dagmara Avelar
03/21/2025 House Rule 19(a) / Re-referred to Rules Committee
04/29/2025 House Added Co-Sponsor Rep. La Shawn K. Ford
05/14/2025 House Added Co-Sponsor Rep. Joyce Mason